Evidence map›Paper›PMID 32407006›Full record

ArticleMolecular systems biology2020

Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver.

Vanessa Dubois, Céline Gheeraert, Wouter Vankrunkelsven, Julie Dubois-Chevalier, Hélène Dehondt, Marie Bobowski-Gerard, Manjula Vinod, Francesco Paolo Zummo, Fabian Güiza, Maheul Ploton and 20 more

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Influencing factors and mechanism of hepatocyte regeneration.Journal of translational medicine · 2025
    Review
  8. Article
  9. Review
  10. The role of SIRT1 in kidney diseases.International urology and nephrology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 5 institutions in 4 countries.

Vanessa DuboisInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.ORCID 0000-0001-8894-2980
Céline Gheeraert *Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Wouter Vankrunkelsven *Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0003-0943-043X
Julie Dubois-Chevalier *Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Hélène Dehondt *Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Marie Bobowski-GerardInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.ORCID 0000-0002-0915-0799
Manjula VinodInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.ORCID 0000-0001-8699-0372
Francesco Paolo ZummoInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Fabian GüizaClinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0001-7026-0957
Maheul PlotonInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Emilie DorchiesInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Laurent PineauInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Alexis BoulinguiezInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Emmanuelle VallezInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Eloise WoitrainInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Eric BaugéInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Fanny LalloyerInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Christian DuhemInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Nabil RabhiUMR 8199 - EGID, CNRS, Institut Pasteur de Lille, University of Lille, Lille, France.
Ronald E van KesterenCenter for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands.ORCID 0000-0002-9592-3777
Cheng-Ming ChiangSimmons Comprehensive Cancer Center, Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Steve LancelInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Hélène DuezInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Jean-Sébastien AnnicotteUMR 8199 - EGID, CNRS, Institut Pasteur de Lille, University of Lille, Lille, France.
Réjane PaumelleInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Ilse VanhorebeekClinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Greet Van den BergheClinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-5320-1362
Bart StaelsInserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.ORCID 0000-0002-3784-1503
Philippe Lefebvre *Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.
Jérôme Eeckhoute *Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille, Lille, France.ORCID 0000-0002-7222-9264
Inserm · FRKU Leuven · BECentre National de la Recherche Scientifique · FRAmsterdam Neuroscience · NLThe University of Texas Southwestern Medical Center · US

Funding

Opposing Functions of BRD4 Isoforms in Breast CancerR01CA251698 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHIANG, CHENG-MING · 2020 to 2024
$2.3M
NCI NIH HHS R01 CA251698
6 · The paper itself

Abstract

Liver injury triggers adaptive remodeling of the hepatic transcriptome for repair/regeneration. We demonstrate that this involves particularly profound transcriptomic alterations where acute induction of genes involved in handling of endoplasmic reticulum stress (ERS) is accompanied by partial hepatic dedifferentiation. Importantly, widespread hepatic gene downregulation could not simply be ascribed to cofactor squelching secondary to ERS gene induction, but rather involves a combination of active repressive mechanisms. ERS acts through inhibition of the liver-identity (LIVER-ID) transcription factor (TF) network, initiated by rapid LIVER-ID TF protein loss. In addition, induction of the transcriptional repressor NFIL3 further contributes to LIVER-ID gene repression. Alteration to the liver TF repertoire translates into compromised activity of regulatory regions characterized by the densest co-recruitment of LIVER-ID TFs and decommissioning of BRD4 super-enhancers driving hepatic identity. While transient repression of the hepatic molecular identity is an intrinsic part of liver repair, sustained disequilibrium between the ERS and LIVER-ID transcriptional programs is linked to liver dysfunction as shown using mouse models of acute liver injury and livers from deceased human septic patients.

Indexed as

AnimalsBasic-Leucine Zipper Transcription FactorsBromodomain Containing ProteinsCell Cycle ProteinsCell LineCells, CulturedChemical and Drug Induced Liver InjuryChromatin Immunoprecipitation SequencingDown-RegulationEndoplasmic Reticulum StressGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHepatocytesHumansLiver DiseasesBasic-Leucine Zipper Transcription FactorsBRD4 protein, humanBrd4 protein, mouseBromodomain Containing ProteinsCell Cycle ProteinsNFIL3 protein, humanNfil3 protein, mouseNuclear ProteinsThapsigarginTranscription Factorsliver injuryNFIL3PAR-bZIPsepsissuper-enhancer

Identifiers

PMID32407006
PMCPMC7224309
OpenAlexW3024451001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.